⌘K

Login Start Free

Home/Filings/4/0001104659-25-063969

4//SEC Filing

Griffiths Richard Ian 4

Accession 0001104659-25-063969

CIK 0001479615other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 12:31 PM ET

Size

9.6 KB

Accession

0001104659-25-063969

Insider Transaction Report

Form 4

Period: 2025-06-26

Silence Therapeutics plcSLN

Griffiths Richard Ian

10% Owner

Transactions

Purchase
American Depositary Shares
2025-06-26+20,735→ 11,600,908 total
Exercise: $5.67→ Ordinary Shares (62,205 underlying)
Purchase
American Depositary Shares
2025-06-27+24,000→ 11,624,908 total
Exercise: $5.82→ Ordinary Shares (72,000 underlying)
Purchase
American Depositary Shares
2025-06-26+65,739→ 11,580,173 total
Exercise: $5.91→ Ordinary Shares (197,217 underlying)

Footnotes (1)

[F1]Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.

Documents

1 file

4
tm2519448-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Silence Therapeutics plc

CIK 0001479615

Entity typeother

Related Parties

1

filerCIK 0001846370

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 12:31 PM ET
Size: 9.6 KB

View on SEC.gov